Pacific Biosciences of California Inc (NASDAQ:PACB) shares, rose in value on Thursday, March 27, with the stock price down by -2.36% to the previous day’s close as strong demand from buyers drove the stock to $1.24.
Actively observing the price movement in the last trading, the stock closed the session at $1.27, falling within a range of $1.22 and $1.36. The value of beta (5-year monthly) was 1.859. Referring to stock’s 52-week performance, its high was $3.89, and the low was $1.16. On the whole, PACB has fluctuated by -23.93% over the past month.
With the market capitalization of Pacific Biosciences of California Inc currently standing at about $369.34 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-12.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 161.65M, with a low estimate of 31.29M and a high estimate of 35.13M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 33.59M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PACB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of PACB currently trading nearly -4.27% and -16.07% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.50, while the 7-day volatility ratio is showing 6.58% which for the 30-day chart, stands at 8.18%. Furthermore, Pacific Biosciences of California Inc (PACB)’s beta value is 2.01, and its average true range (ATR) is 0.12.
A comparison of Pacific Biosciences of California Inc (PACB) with its peers suggests the former has fared considerably weaker in the market. PACB showed an intraday change of -2.36% in last session, and over the past year, it shrunk by -65.65%%.
Data on historical trading for Pacific Biosciences of California Inc (NASDAQ:PACB) indicates that the trading volumes over the past 10 days have averaged 7.05 and over the past 3 months, they’ve averaged 11.17 million. According to company’s latest data on outstanding shares, there are 294.42 million shares outstanding.
Nearly 11.61% of Pacific Biosciences of California Inc’s shares belong to company insiders and institutional investors own 77.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 53.41 million shares as on 2025-03-14, resulting in a short ratio of 3.95. According to the data, the short interest in Pacific Biosciences of California Inc (PACB) stood at 2039.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 66.69 million. The stock has fallen by -32.24% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PACB stock heading into the next quarter.
